tiprankstipranks
Trending News
More News >
Annovis Bio (ANVS)
NYSE:ANVS
US Market

Annovis Bio (ANVS) Income Statement

Compare
716 Followers

Annovis Bio Income Statement

Last quarter (Q3 2025), Annovis Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Annovis Bio's net income was $-7.26M. See Annovis Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 26.69M$ 45.03M$ 25.51M$ 14.54M$ 6.64M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 6.64M
EBITDA
$ -26.69M$ -45.03M$ -25.51M$ -14.50M$ 0.00
Operating Income
$ -26.69M$ -45.03M$ -25.51M$ -14.54M$ -6.64M
Other Income/Expenses
$ 2.10M$ -11.17M$ 182.71K$ 50.09K$ 1.18M
Pretax Income
$ -24.59M$ -56.20M$ -25.33M$ -14.49M$ -5.46M
Net Income
$ -24.59M$ -56.20M$ -25.33M$ -14.49M$ -5.46M
Per Share Metrics
Basic EPS
$ -2.02K$ -6.23$ -3.10$ -1.90$ -0.87
Diluted EPS
$ -2.01K$ -6.23$ -3.10$ -1.90$ -0.87
Weighted Average Shares Outstanding
12.18M 9.02M 8.16M 7.63M 6.31M
Weighted Average Shares Outstanding (Diluted)
12.23M 9.02M 8.16M 7.63M 6.31M
Currency in USD

Annovis Bio Earnings and Revenue History